Reid M S, Hsu K, Berger S P
University of California, San Francisco, Langley Porter Psychiatric Institute, Veteran's Affairs Medical Center 94121, USA.
Synapse. 1997 Oct;27(2):95-105. doi: 10.1002/(SICI)1098-2396(199710)27:2<95::AID-SYN1>3.0.CO;2-6.
The effects of cocaine and d-amphetamine on extracellular glutamate and aspartate levels in the nucleus accumbens, prefrontal cortex, and striatum were studied by in vivo microdialysis in awake, freely moving rats. In the nucleus accumbens, glutamate levels were stimulated by cocaine (15-30 mg/kg, i.p.), GBR 12909 (15 mg/kg, i.p.), and d-amphetamine (2 mg/kg, i.p.), while aspartate levels were not affected. The increase in nucleus accumbens glutamate levels following cocaine (30 mg/kg) was calcium-dependent and was blocked by pretreatment with dopamine antagonists; haloperidol (0.2 mg/kg, i.p.), SCH 23390 (0.02 mg/kg, i.p.), and raclopride (1 mg/kg, i.p.), as well as local 6-OHDA lesions of the nucleus accumbens. In the prefrontal cortex, glutamate levels were stimulated by both cocaine (15-30 mg/kg, i.p.) and d-amphetamine (2 mg/kg, i.p.), while aspartate levels were moderately stimulated by d-amphetamine only. The increase in prefrontal cortex glutamate levels following cocaine (30 mg/kg) was calcium-dependent and was blocked by pretreatment with SCH 23390 (0.02 mg/kg, i.p.), but not haloperidol (0.2 mg/kg, i.p.) or raclopride (1 mg/kg, i.p.). In the striatum, glutamate and aspartate levels were not affected by either cocaine (15-30 mg/kg, i.p.) or d-amphetamine (2 mg/kg, i.p.). These findings demonstrate that stimulants enhance glutamate release in limbic brain structures, nucleus accumbens, and prefrontal cortex, but not extrapyamidal brain structures, striatum. Furthermore, the increase in glutamate release in the nucleus accumbens may be mediated by dopamine.
通过对清醒、自由活动的大鼠进行体内微透析,研究了可卡因和右旋苯丙胺对伏隔核、前额叶皮质和纹状体细胞外谷氨酸和天冬氨酸水平的影响。在伏隔核中,可卡因(15 - 30毫克/千克,腹腔注射)、GBR 12909(15毫克/千克,腹腔注射)和右旋苯丙胺(2毫克/千克,腹腔注射)可刺激谷氨酸水平,而天冬氨酸水平不受影响。可卡因(30毫克/千克)引起的伏隔核谷氨酸水平升高依赖于钙,并可被多巴胺拮抗剂预处理阻断;氟哌啶醇(0.2毫克/千克,腹腔注射)、SCH 23390(0.02毫克/千克,腹腔注射)和雷氯必利(1毫克/千克,腹腔注射),以及伏隔核局部6 - 羟基多巴胺损伤。在前额叶皮质中,可卡因(15 - 30毫克/千克,腹腔注射)和右旋苯丙胺(2毫克/千克,腹腔注射)均可刺激谷氨酸水平,而天冬氨酸水平仅被右旋苯丙胺适度刺激。可卡因(30毫克/千克)引起的前额叶皮质谷氨酸水平升高依赖于钙,并可被SCH 23390(0.02毫克/千克,腹腔注射)预处理阻断,但不能被氟哌啶醇(0.2毫克/千克,腹腔注射)或雷氯必利(1毫克/千克,腹腔注射)阻断。在纹状体中,谷氨酸和天冬氨酸水平均不受可卡因(15 - 30毫克/千克,腹腔注射)或右旋苯丙胺(2毫克/千克,腹腔注射)的影响。这些发现表明,兴奋剂可增强边缘脑结构、伏隔核和前额叶皮质中的谷氨酸释放,但不影响锥体外脑结构纹状体。此外,伏隔核中谷氨酸释放的增加可能由多巴胺介导。